Abbonarsi

Validation of a natural language processing algorithm to identify adenomas and measure adenoma detection rates across a health system: a population-level study - 13/12/22

Doi : 10.1016/j.gie.2022.07.009 
Jill Tinmouth, MD, PhD 1, 2, 3, 4, , Deepak Swain, MHI 1, Katherine Chorneyko, MD 5, Vicki Lee, MPH 1, Barbara Bowes, MPH 6, Yingzi Li, MSc 1, Julia Gao, MSc 1, David Morgan, MD, MSc 7, 8
1 ColonCancerCheck Program, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada 
2 Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada 
3 Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 
4 Division of Gastroenterology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada 
5 Laboratory Services, Brantford General Hospital, Brantford, Ontario, Canada 
6 Women’s College Hospital, Toronto, Ontario, Canada 
7 Service of Gastroenterology, St Joseph’s Hospital, Hamilton, Ontario, Canada 
8 Division of Gastroenterology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada 

Reprint requests: Jill Tinmouth, MD, PhD, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Rm HG 40, Toronto, Ontario, Canada, M4N 3M5.Sunnybrook Health Sciences Centre2075 Bayview AveRm HG 40TorontoOntarioM4N 3M5Canada

Abstract

Background and Aims

Measuring adenoma detection rates (ADRs) at the population level is challenging because pathology reports are often reported in an unstructured format; further, there is significant variation in reporting methods across institutions. Natural language processing (NLP) can be used to extract relevant information from text-based records. We aimed to develop and validate an NLP algorithm to identify colorectal adenomas that could be used to report ADR at the population level in Ontario, Canada.

Methods

The sampling frame included pathology reports from all colonoscopies performed in Ontario in 2015 and 2016. Two random samples of 450 and 1000 reports were selected as the training and validation sets, respectively. Expert clinicians reviewed and classified reports as adenoma or other. The training set was used to develop an NLP algorithm (to identify adenomas) that was evaluated using the validation set. The NLP algorithm test characteristics were calculated using expert review as the reference. We used the algorithm to measure ADR for all endoscopists in Ontario in 2019.

Results

The 1450 pathology reports were derived from 62 laboratories, 266 pathologists, and 532 endoscopists. In the training set, the NLP algorithm for any adenoma had a sensitivity of 99.60% (95% confidence interval (CI), 97.77-99.99), specificity of 99.01% (95% CI, 96.49-99.88), positive predictive value of 99.19% (95% CI, 97.12-99.90), and F1 score of .99. Similar results were obtained for the validation set. The median ADR was 33% (interquartile range, 26%-40%).

Conclusions

When we used a population-based sample from Ontario, our NLP algorithm was highly accurate and was used at the system level to measure ADR.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ADR, CI, CCO, eMaRC, NLP, NPV, OHIP, PPV


Mappa


 DISCLOSURE: The following authors disclosed financial relationships: J. Tinmouth, D. Swain, V. Lee, Y. Li, J. Gao: Employee of Ontario Health (Cancer Care Ontario). Research support for this study was provided by Ontario Health (Cancer Care Ontario).


© 2023  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 97 - N° 1

P. 121 - gennaio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Second-generation distal attachment cuff for adenoma detection in screening colonoscopy: a randomized multicenter study
  • Katharina Zimmermann-Fraedrich, Susanne Sehner, Thomas Rösch, Jens Aschenbeck, Andreas Schröder, Stefan Schubert, Thomas Liceni, Alireza Aminalai, Wolfgang Spitz, Ulrich Möhler, Frank Heller, Rüdiger Berndt, Cordula Bartel-Kowalski, Katrin Niemax, Wolfgang Burmeister, Guido Schachschal
| Articolo seguente Articolo seguente
  • Monitoring colonoscopy screening program quality at the provider level, the institution level, and beyond
  • Joshua Melson

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.